Diseases [C] » Infections [C01] » Sepsis » Shock, Septic
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Inflammation » Systemic Inflammatory Response Syndrome » Sepsis » Shock, Septic
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Shock » Systemic Inflammatory Response Syndrome » Shock, Septic
Description
Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. MeSH
Hierarchy View
Approved Indicated Drugs (5)
Phase 4 Indicated Drugs (36)
Phase 3 Indicated Drugs (51)
Phase 2 Indicated Drugs (22)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (17)
Organization Involved with Phase 4 Indications (39)
Association Niçoise de Réanimation Médicale
Australian and New Zealand Intensive Care Society Clinical Trials Group
Hoosier Cancer Research Network
Institute of Liver and Biliary Sciences, India
Laboratoire français de Fractionnement et de Biotechnologies
Methodist Cancer Center, Houston, Texas
National Center for Advancing Translational Science (NCATS)
National Center for Research Resources (NCRR)
Organization Involved with Phase 3 Indications (105)
American British Cowdray Medical Center
A.O. Ospedale Maggiore di Lodi
AOU S. Luigi Gonzaga, Orbassano
Aragon Institute of Health Sciences
Assistance Publique - Hôpitaux de Paris
Baqiyatallah Medical Sciences University
Canadian Critical Care Trials Group
Canadian Institutes of Health Research (CIHR)
Centre Hospitalier de Cherbourg
Centre Hospitalier de Tourcoing
Centre Hospitalier de Valenciennes
Centre Hospitalier Régional d'Orléans
European Society of Intensive Care Medicine
German Federal Ministry of Education and Research
Hamadan University of Medical Science
Hôpital Saint Philibert, Lomme
Hospital de St. António dos Capuchos
Hospital general Universitario de Ciudad Real
IMSS Hospital General de Zona 11
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
National Heart, Lung, and Blood Institute (NHLBI)
National Hepatology & Tropical Medicine Research Institute
National Institutes of Health (NIH)
People's Liberation Army of China
Postgraduate Institute of Medical Education and Research
St. Joseph Hospital Health Center
Organization Involved with Phase 2 Indications (57)
National Institute of General Medical Sciences (NIGMS)
National Research Foundation of Korea
Northern Health and Social Care Trust
Northern Hospital, Epping, Victoria, Australia
Ontario Institute for Regenerative Medicine (OIRM)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (42)
Fundação de Amparo à Pesquisa do Estado de São Paulo
Huazhong University of Science and Technology
Icahn School of Medicine at Mount Sinai
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.